annual cash & cash equivalents:
$239.09M+$22.63M(+10.46%)Summary
- As of today (September 12, 2025), VCYT annual cash & cash equivalents is $239.09 million, with the most recent change of +$22.63 million (+10.46%) on December 31, 2024.
- During the last 3 years, VCYT annual cash & cash equivalents has risen by +$65.89 million (+38.04%).
- VCYT annual cash & cash equivalents is now -31.57% below its all-time high of $349.36 million, reached on December 31, 2020.
Performance
VCYT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$320.72M+$33.36M(+11.61%)Summary
- As of today (September 12, 2025), VCYT quarterly cash & cash equivalents is $320.72 million, with the most recent change of +$33.36 million (+11.61%) on June 30, 2025.
- Over the past year, VCYT quarterly cash & cash equivalents has increased by +$84.80 million (+35.95%).
- VCYT quarterly cash & cash equivalents is now -8.20% below its all-time high of $349.36 million, reached on December 31, 2020.
Performance
VCYT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VCYT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | +36.0% |
| 3 y3 years | +38.0% | +95.6% |
| 5 y5 years | +50.1% | +117.5% |
VCYT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.0% | at high | +95.6% |
| 5 y | 5-year | -31.6% | +55.0% | -8.2% | +117.5% |
| alltime | all time | -31.6% | +3060.0% | -8.2% | +2190.5% |
VCYT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $320.72M(+11.6%) |
| Mar 2025 | - | $287.36M(-0.7%) |
| Dec 2024 | $239.09M(+10.5%) | $289.44M(+5.6%) |
| Sep 2024 | - | $274.08M(+16.2%) |
| Jun 2024 | - | $235.91M(+12.8%) |
| Mar 2024 | - | $209.19M(-3.4%) |
| Dec 2023 | $216.45M(+40.3%) | $216.45M(+6.9%) |
| Sep 2023 | - | $202.46M(+5.9%) |
| Jun 2023 | - | $191.14M(+7.4%) |
| Mar 2023 | - | $177.89M(-0.5%) |
| Dec 2022 | $154.25M(-10.9%) | $178.85M(+5.1%) |
| Sep 2022 | - | $170.11M(+3.7%) |
| Jun 2022 | - | $164.00M(+0.2%) |
| Mar 2022 | - | $163.62M(-5.5%) |
| Dec 2021 | $173.20M(-50.4%) | $173.20M(+5.6%) |
| Sep 2021 | - | $164.03M(-49.9%) |
| Jun 2021 | - | $327.55M(+1.1%) |
| Mar 2021 | - | $324.06M(-7.2%) |
| Dec 2020 | $349.36M | $349.36M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $345.08M(+134.0%) |
| Jun 2020 | - | $147.45M(-3.7%) |
| Mar 2020 | - | $153.13M(+158.1%) |
| Dec 2019 | $159.32M(+104.3%) | - |
| Dec 2018 | $78.00M(+130.1%) | - |
| Dec 2017 | $33.89M(-42.8%) | - |
| Dec 2016 | $59.22M(+51.5%) | $59.34M(+51.4%) |
| Dec 2015 | $39.08M(+11.6%) | $39.20M(-15.0%) |
| Sep 2015 | - | $46.12M(-9.7%) |
| Jun 2015 | - | $51.05M(+97.9%) |
| Mar 2015 | - | $25.80M(-26.3%) |
| Dec 2014 | $35.01M(-50.8%) | $35.01M(-20.4%) |
| Sep 2014 | - | $44.00M(-24.1%) |
| Jun 2014 | - | $58.00M(-9.7%) |
| Mar 2014 | - | $64.24M(-9.8%) |
| Dec 2013 | $71.22M(+408.6%) | $71.22M(+361.7%) |
| Sep 2013 | - | $15.43M(-25.4%) |
| Jun 2013 | - | $20.68M(+47.7%) |
| Dec 2012 | $14.00M(+85.1%) | $14.00M |
| Dec 2011 | $7.57M | - |
FAQ
- What is Veracyte, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Veracyte, Inc.?
- What is Veracyte, Inc. annual cash & cash equivalents year-on-year change?
- What is Veracyte, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Veracyte, Inc.?
- What is Veracyte, Inc. quarterly cash & cash equivalents year-on-year change?
What is Veracyte, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of VCYT is $239.09M
What is the all time high annual cash & cash equivalents for Veracyte, Inc.?
Veracyte, Inc. all-time high annual cash & cash equivalents is $349.36M
What is Veracyte, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, VCYT annual cash & cash equivalents has changed by +$22.63M (+10.46%)
What is Veracyte, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of VCYT is $320.72M
What is the all time high quarterly cash & cash equivalents for Veracyte, Inc.?
Veracyte, Inc. all-time high quarterly cash & cash equivalents is $349.36M
What is Veracyte, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, VCYT quarterly cash & cash equivalents has changed by +$84.80M (+35.95%)